早期慢性阻塞性肺病中中性粒细胞及其前体的系统性改变
Theodore S Kapellos1, Kevin Baßler2, Wataru Fujii2
1Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, 53115 Bonn, Germany; Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity (LHI), Member of the German Center for Lung Research (DZL), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
血液中性粒细胞在早期慢性阻塞性肺病 (COPD) 中表现出分子变化,与肺功能下降相关. 中性粒细胞和前体的这些系统性变化可能提供早期诊断生物标志物和COPD的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部医学 肺部医学
- 分子生物学分子生物学
背景情况:
- 系统性炎症是严重肺部疾病的已知因素.
- 在肺部疾病早期阶段,外周免疫细胞的分子,功能和表型变化尚未得到充分理解.
- 慢性阻塞性肺病 (COPD) 是一种严重的呼吸系统疾病,其特征是气道炎症,肺气和呼吸困难.
研究的目的:
- 研究COPD早期的外周免疫细胞的分子,功能和表型特征.
- 为了确定免疫细胞的变化是否与疾病严重程度和肺功能相关.
- 探索早期COPD干预的潜在诊断生物标志物和治疗目标.
主要方法:
- 利用单细胞分析来检查COPD早期患者的外周免疫细胞.
- 评估了卷烟烟雾暴露的小鼠模型中的中性粒细胞及其骨髓前体.
- 与肺功能参数相关的分子和功能性中性粒细胞状态.
主要成果:
- 在早期的COPD中观察到血中中性粒细胞数量的增加.
- 发现中性粒细胞的分子和功能变化与肺功能下降相关.
- 在人类的COPD和小鼠模型中,在血液中性粒细胞及其前体中发现了类似的分子变化,影响了血液和肺组织.
结论:
- 中性粒细胞及其前体的系统分子变化存在于早期的慢性肺炎中.
- 这些发现表明,中性粒细胞及其前体可以作为早期COPD诊断和患者分层的潜在生物标志物.
- 对这些系统性变化的进一步研究可能会揭示COPD的新型治疗点.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pneumonia II: Pathophysiology


